{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:07:27Z","timestamp":1793844447301,"version":"4.6.1"},"reference-count":169,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.survophthal.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:11:41Z","timestamp":1772151101000},"page":"1044-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review"],"prefix":"10.1016","volume":"71","author":[{"given":"Sing Yue","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lik Thai","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharliza","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishwanath","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranine","family":"Mankongcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-5371","authenticated-orcid":false,"given":"Sagnik","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICU.0000000000000657","article-title":"Age-related macular degeneration therapy: a review","volume":"31","author":"Ammar","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on retinal vein occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib4","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.3390\/ijms24119591","article-title":"Current treatments for diabetic macular edema","volume":"24","author":"Tatsumi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11892-021-01403-6","article-title":"Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema","volume":"21","author":"Everett","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajo.2011.04.015","article-title":"Does laser still have a role in the management of retinal vascular and neovascular diseases?","volume":"152","author":"Shah","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib7","first-page":"2351","article-title":"Lasers in ophthalmology: past, present and future","volume":"50","author":"Munnerlyn","year":"2003","journal-title":"J Mod Opt"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1152\/japplphysiol.01267.2001","article-title":"Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance","volume":"92","author":"Kregel","year":"2002","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000458","article-title":"Laser resensitization of medically unresponsive neovascular age-related macular degeneration: efficacy and implications","volume":"35","author":"Luttrull","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.02.006_bib10","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2147\/OPTH.S268322","article-title":"Slowed progression of age-related geographic atrophy following subthreshold laser","volume":"14","author":"Luttrull","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.preteyeres.2016.03.001","article-title":"Heat shock proteins in the retina: focus on HSP70 and alpha crystallins in ganglion cell survival","volume":"52","author":"Piri","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1167\/iovs.11-8585","article-title":"Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases","volume":"53","author":"Zhang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.survophthal.2013.09.004","article-title":"Trophic factors in the pathogenesis and therapy for retinal degenerative diseases","volume":"59","author":"Kolomeyer","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal photocoagulation: a review of complications","volume":"33","author":"Reddy","year":"2018","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/157339912800840523","article-title":"Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review","volume":"8","author":"Luttrull","year":"2012","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjo.2004.051540","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema","volume":"89","author":"Luttrull","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/IAE.0000000000000177","article-title":"Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity","volume":"34","author":"Luttrull","year":"2014","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/IAE.0b013e3182206f6c","article-title":"Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema","volume":"32","author":"Luttrull","year":"2012","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib19","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0161-6420(97)30061-X","article-title":"The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser","volume":"104","author":"Friberg","year":"1997","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib20","first-page":"203","article-title":"Sublethal photothermal stress stimulates the secretion of anti-angiogenic proteins from retinal pigment epithelial cells","volume":"71","author":"Inagaki","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/IAE.0000000000002356","article-title":"Changes of aqueous humor m\u00fcller cells\u2019 biomarkers in human patients affected by diabetic macular edema after subthreshold micropulse laser treatment","volume":"40","author":"Midena","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.02.006_bib22","article-title":"Role of 532\u2009nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks","volume":"12","author":"Ambiya","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib23","first-page":"9","article-title":"Temperature profiles in human retina and choroid during laser coagulation with different wavelengths ranging from 514 to 810 nm","volume":"5","author":"Vogel","year":"1992","journal-title":"Lasers Light Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib24","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1167\/iovs.12-11382","article-title":"The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina","volume":"54","author":"Yu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12886-018-0841-z","article-title":"Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema","volume":"18","author":"Chhablani","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/112067210801800613","article-title":"Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study","volume":"18","author":"Lanzetta","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib27","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41433-022-02136-w","article-title":"Subthreshold laser therapy guidelines for retinal diseases","volume":"36","author":"Chhablani","year":"2022","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.9.9.15","article-title":"International retinal laser society guidelines for subthreshold laser treatment","volume":"9","author":"Keunen","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib29","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Early treatment diabetic retinopathy study report number 1. Early Treatment diabetic retinopathy study research group","volume":"103","author":"Photocoagulation for diabetic macular edema","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0161-6420(90)32574-5","article-title":"Choroidal neovascularization after laser photocoagulation for diabetic macular edema","volume":"97","author":"Lewis","year":"1990","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0161-6420(89)32924-1","article-title":"Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation","volume":"96","author":"Morgan","year":"1989","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0002-9394(14)74789-0","article-title":"Subretinal fibrosis after laser photocoagulation for diabetic macular edema","volume":"113","author":"Smith","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjo.2004.051540","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema","volume":"89","author":"Luttrull","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/bjo.2003.040949","article-title":"Subthreshold micropulse diode laser treatment in diabetic macular oedema","volume":"88","author":"Laursen","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1442-9071.2007.01566.x","article-title":"Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up","volume":"35","author":"Sivaprasad","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/eye.2009.207","article-title":"Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema","volume":"24","author":"Nakamura","year":"2010","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10384-011-0033-3","article-title":"Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema","volume":"55","author":"Takatsuna","year":"2011","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3341\/kjo.2014.28.5.379","article-title":"The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema","volume":"28","author":"Kwon","year":"2014","journal-title":"Korean J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib39","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/eye.2014.264","article-title":"Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness","volume":"28","author":"Mansouri","year":"2014","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib40","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/IAE.0000000000000521","article-title":"Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: morphologic and functional safety","volume":"35","author":"Vujosevic","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.02.006_bib41","article-title":"Micropulse laser in patients with refractory and treatment-na\u00efve center-involved diabetic macular edema: short terms visual and anatomic outcomes","volume":"13","author":"Valera-Cornejo","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40942-020-00268-3","article-title":"Real-life outcomes of subthreshold laser therapy for diabetic macular edema","volume":"7","author":"Passos","year":"2021","journal-title":"Int J Retin Vitr"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2022.08.012","article-title":"Diabetic macular edema and diode subthreshold micropulse laser: a randomized double-masked noninferiority clinical trial","volume":"130","author":"Lois","year":"2023","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.5301\/ejo.5000495","article-title":"Yellow micropulse laser in diabetic macular edema: a short-term pilot study","volume":"24","author":"Nicol\u00f2","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10103-018-2672-9","article-title":"The impact of central foveal thickness on the efficacy of subthreshold micropulse yellow laser photocoagulation in diabetic macular edema","volume":"34","author":"Citirik","year":"2019","journal-title":"Lasers Med Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.joco.2016.08.007","article-title":"Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema","volume":"28","author":"Fazel","year":"2016","journal-title":"J Curr Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2008.146712","article-title":"Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema","volume":"93","author":"Figueira","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib48","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/IAE.0b013e3181c96986","article-title":"Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation","volume":"30","author":"Vujosevic","year":"2010","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib49","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1167\/iovs.10-6828","article-title":"Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema","volume":"52","author":"Lavinsky","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib50","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/IAE.0000000000001053","article-title":"Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials","volume":"36","author":"Chen","year":"2016","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib51","first-page":"1020","article-title":"Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: a meta-analysis of randomized controlled trials","volume":"9","author":"Qiao","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib52","article-title":"Monotherapy laser photocoagulation for diabetic macular oedema","volume":"10","author":"Jorge","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10792-019-01280-9","article-title":"Aflibercept plus micropulse laser versus aflibercept monotherapy for diabetic macular edema: 1-year results of a randomized clinical trial","volume":"40","author":"Abouhussein","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib54","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s10103-021-03306-0","article-title":"Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema","volume":"36","author":"Alt\u0131nel","year":"2021","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.survophthal.2026.02.006_bib55","article-title":"Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one-year-follow-up","volume":"13","author":"El Matri","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12886-020-01576-w","article-title":"Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial","volume":"20","author":"Furashova","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib57","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2147\/OPTH.S360869","article-title":"Treatment of diabetic macular edema with aflibercept and micropulse laser (DAM study)","volume":"16","author":"Koushan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14444-y","article-title":"Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema","volume":"12","author":"Tatsumi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.02.006_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biopha.2017.10.078","article-title":"Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: a Bayesian network meta-analysis","volume":"97","author":"Wu","year":"2018","journal-title":"Biomed Pharm"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib60","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.4103\/IJO.IJO_519_23","article-title":"Comparison of micropulse subthreshold laser plus anti-VEGF versus anti-VEGF alone in diabetic macular edema: systematic review","volume":"71","author":"Lubis","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000458539","article-title":"Guidelines for the management of diabetic macular edema by the European society of retina specialists (EURETINA)","volume":"237","author":"Schmidt-Erfurth","year":"2017","journal-title":"Ophthalmologica"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067684","article-title":"Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400\u00b5: a cost-effectiveness analysis from the DIAMONDS trial","volume":"13","author":"Mistry","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.survophthal.2026.02.006_bib63","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/OPTH.S87499","article-title":"Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy","volume":"9","author":"Abd Elhamid","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib64","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/OPTH.S112431","article-title":"Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy","volume":"10","author":"Ambiya","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40942-021-00335-3","article-title":"Safety of various parameter sets with navigated microsecond pulsing laser in central serous chorioretinopathy","volume":"7","author":"Chhablani","year":"2021","journal-title":"Int J Retin Vitr"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib67","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib68","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00417-017-3783-x","article-title":"Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser","volume":"255","author":"Gaw\u0119cki","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib69","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/jcm8091398","article-title":"Transfoveal micropulse laser treatment of central serous chorioretinopathy within six months of disease onset","volume":"8","author":"Gaw\u0119cki","year":"2019","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib70","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.18240\/ijo.2020.09.11","article-title":"Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy","volume":"13","author":"I\u015f\u0131k","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib71","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00417-015-2965-7","article-title":"Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy","volume":"253","author":"Kim","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib72","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-018-0309-7","article-title":"Short-duration multiple-session subthreshold micropulse yellow laser (577\u2009nm) for chronic central serous chorioretinopathy: results at 3 years","volume":"33","author":"Kim","year":"2019","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib73","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s10103-022-03574-4","article-title":"Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy","volume":"37","author":"Kiraly","year":"2022","journal-title":"Lasers Med Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12886-022-02330-0","article-title":"577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study","volume":"22","author":"Long","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib75","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/jcm10112418","article-title":"Influence of retinal microsecond pulse laser treatment in central serous chorioretinopathy: a short-term optical coherence tomography angiography study","volume":"10","author":"Prasuhn","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000439600","article-title":"Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy","volume":"234","author":"Scholz","year":"2015","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib77","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s00417-021-05256-3","article-title":"Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy","volume":"259","author":"Schworm","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib78","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","article-title":"Micropulsed diode laser therapy: evolution and clinical applications","volume":"55","author":"Sivaprasad","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib79","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10103-020-03129-5","article-title":"The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy","volume":"36","author":"Uzlu","year":"2021","journal-title":"Lasers Med Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/eye.2014.315","article-title":"Subthreshold micropulse yellow laser (577\u2009nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome","volume":"29","author":"Yadav","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.02.006_bib81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib82","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1167\/iovs.10-5917","article-title":"Non-damaging retinal phototherapy: dynamic range of heat shock protein expression","volume":"52","author":"Sramek","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib83","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1177\/11206721211064021","article-title":"Navigated micropulse laser for central serous chorioretinopathy: efficacy, safety, and predictive factors of treatment response","volume":"32","author":"Amoroso","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41433-018-0029-z","article-title":"Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy","volume":"32","author":"Ntomoka","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.02.006_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-024-06666-9","article-title":"Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy","author":"Toto","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"Arora","year":"2019","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.survophthal.2026.02.006_bib87","article-title":"Subthreshold micropulse laser vs. conventional laser for central serous chorioretinopathy: a randomized controlled clinical trial","volume":"8","author":"Zhou","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib88","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12886-022-02331-z","article-title":"Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy","volume":"22","author":"Zeng","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib89","doi-asserted-by":"crossref","first-page":"921","DOI":"10.18240\/ijo.2023.06.14","article-title":"Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy","volume":"16","author":"Guo","year":"2023","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib90","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bjophthalmol-2017-311291","article-title":"Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group","volume":"102","author":"Roca","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3513794","article-title":"Low-fluence photodynamic therapy versus subthreshold micropulse yellow wavelength laser in the treatment of chronic central serous chorioretinopathy","volume":"2016","author":"\u00d6zmert","year":"2016","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib92","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/eye.2016.142","article-title":"Comparison of subthreshold micropulse laser (577\u2009nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"30","author":"Scholz","year":"2016","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib93","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jfo.2020.08.027","article-title":"Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"44","author":"Altinel","year":"2021","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12886-022-02472-1","article-title":"OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib95","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/aos.12938","article-title":"Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol","volume":"94","author":"Breukink","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib96","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjophthalmol-2020-316076","article-title":"Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy","volume":"105","author":"Ho","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000456676","article-title":"Effect of photodynamic therapy on optical coherence tomography angiography in eyes with chronic central serous chorioretinopathy","volume":"237","author":"Xu","year":"2017","journal-title":"Ophthalmologica"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib98","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3928\/23258160-20150909-08","article-title":"Randomized clinical trial to compare micropulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy","volume":"46","author":"Kretz","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib99","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/aos.14775","article-title":"Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser","volume":"99","author":"van Rijssen","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib100","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ophtha.2018.11.004","article-title":"Re: van Dijk et al.: half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547\u20131555)","volume":"126","author":"Battaglia Parodi","year":"2019","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib101","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib102","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00417-008-1014-1","article-title":"Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy","volume":"247","author":"Ricci","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib103","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1442-9071.2009.02157.x","article-title":"Micropulse diode laser photocoagulation for central serous chorio-retinopathy","volume":"37","author":"Gupta","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib104","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3928\/23258160-20130909-08","article-title":"Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial","volume":"44","author":"Roisman","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IAE.0000000000000285","article-title":"Low-intensity\/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy","volume":"35","author":"Malik","year":"2015","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib106","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/IAE.0000000000001005","article-title":"Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopathy","volume":"36","author":"Luttrull","year":"2016","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184112","article-title":"Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy","volume":"12","author":"Maruko","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2026.02.006_bib108","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/OPTH.S180663","article-title":"Going green \u2013 treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser","volume":"12","author":"Khatri","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib109","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40123-022-00625-5","article-title":"Ganglion cell loss in the course of central serous chorioretinopathy","volume":"12","author":"Gaw\u0119cki","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"17","key":"10.1016\/j.survophthal.2026.02.006_bib110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025722","article-title":"Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: a meta-analysis","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib111","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A review of subthreshold micropulse laser for treatment of macular disorders","volume":"34","author":"Scholz","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2026.02.006_bib112","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/OPTH.S160956","article-title":"Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib113","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.oret.2023.10.024","article-title":"Comparing half-dose photodynamic therapy with subthreshold micropulse laser for the treatment of central serous chorioretinopathy","volume":"8","author":"Brelen","year":"2024","journal-title":"Ophthalmol Retin"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.006_bib114","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41433-019-0692-8","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","volume":"34","author":"Sun","year":"2020","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08820538.2020.1809682","article-title":"Subthreshold micro-pulse yellow laser and eplerenone drug therapy in chronic central serous chorio-retinopathy patients: a comparative study","volume":"35","author":"Vignesh","year":"2020","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.13.8.19","article-title":"Subthreshold micropulse laser versus oral spironolactone in chronic central serous chorioretinopathy: a quasi-randomized controlled trial","volume":"13","author":"Gao","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib117","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2012","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib118","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2227424","article-title":"Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China","volume":"55","author":"Zhao","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.survophthal.2026.02.006_bib119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2025.06.012","article-title":"Eplerenone and spironolactone for chronic central serous chorioretinopathy: a systematic review and meta-analysis","volume":"278","author":"Huang","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12886-025-04560-4","article-title":"Selective and nonselective mineralocorticoid receptor antagonists in central serous chorioretinopathy: systematic review and meta-analysis","volume":"26","author":"Park","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100252","article-title":"International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)","author":"Radke","year":"2025","journal-title":"Asia Pac J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib122","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","article-title":"Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"Feenstra","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.02.006_bib123","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3190136","article-title":"Long-term effects of half-time photodynamic therapy on retinal sensitivity in eyes with chronic central serous chorioretinopathy","volume":"2020","author":"Iwase","year":"2020","journal-title":"BioMed Res Int"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib124","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/life13051194","article-title":"Functional outcomes and safety profile of trans-foveal subthreshold micropulse laser in persistent central serous chorioretinopathy","volume":"13","author":"Kiraly","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"Arora","year":"2019","journal-title":"Clin Exp Optom"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib126","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib127","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib128","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10103-020-03225-6","article-title":"Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy","volume":"36","author":"Alt\u0131nel","year":"2021","journal-title":"Lasers Med Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib129","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001386","article-title":"Nondamaging retinal laser therapy for treatment of central serous chorioretinopathy: what is the evidence?","volume":"37","author":"Wood","year":"2017","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib130","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.ophtha.2006.05.056","article-title":"Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser","volume":"113","author":"Parodi","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.02.006_bib131","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/251257","article-title":"Subthreshold micropulse photocoagulation for persistent macular edema secondary to branch retinal vein occlusion including best-corrected visual acuity greater than 20\/40","volume":"2014","author":"Inagaki","year":"2014","journal-title":"J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib132","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1120672117750056","article-title":"Comparison of ranibizumab and subthreshold micropulse laser in treatment of macular edema secondary to branch retinal vein occlusion","volume":"28","author":"Buyru \u00d6zkurt","year":"2018","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib133","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/IAE.0000000000002165","article-title":"Combination therapy of intravitreal ranibizumab and subthreshold micropulse photocoagulation for macular edema secondary to branch retinal vein occlusion: 6-month result","volume":"39","author":"Terashima","year":"2019","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib134","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.12669\/pjms.38.5.5231","article-title":"Clinical efficacy of conbercept plus micropulse laser (577 nm) treatment in macular edema secondary to non-ischemic central retinal vein occlusion","volume":"38","author":"Li","year":"2022","journal-title":"Pak J Med Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib136","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajo.2006.06.015","article-title":"Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study","volume":"142","author":"Klein","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib137","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib138","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40123-017-0086-6","article-title":"A review of current and future management of geographic atrophy","volume":"6","author":"Sacconi","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.006_bib139","article-title":"Laser treatment of drusen to prevent progression to advanced age-related macular degeneration","volume":"2015","author":"Virgili","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2026.02.006_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101017","article-title":"Reticular pseudodrusen: a critical phenotype in age-related macular degeneration","volume":"88","author":"Wu","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib141","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-021-81810-7","article-title":"Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration","volume":"11","author":"Querques","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib142","doi-asserted-by":"crossref","first-page":"474","DOI":"10.18240\/ijo.2022.03.16","article-title":"Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study","volume":"15","author":"Huang","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"21","key":"10.1016\/j.survophthal.2026.02.006_bib143","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.3390\/ijms21218242","article-title":"Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches","volume":"21","author":"Ricci","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2011-301236","article-title":"Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?","volume":"96","author":"Binder","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.006_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202097","article-title":"Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD","volume":"13","author":"Luttrull","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib146","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0161-6420(00)00009-9","article-title":"Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration","volume":"107","author":"Slakter","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib147","first-page":"316","article-title":"Photocoagulation of chorioretinal anastomoses in far-advanced age-related macular degeneration","volume":"20","author":"Cialdini","year":"1989","journal-title":"Ophthalmic Surg"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.006_bib148","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1995.01100110052025","article-title":"Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments","volume":"113","author":"Kuhn","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib149","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00417-004-1082-9","article-title":"Micropulse laser treatment of retinal-choroidal anastomoses in age-related macular degeneration","volume":"243","author":"Johnson","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib150","doi-asserted-by":"crossref","first-page":"NP93","DOI":"10.1177\/1120672120928008","article-title":"Subthreshold micropulse yellow laser for the management of refractory cystoid macular edema consequent to complicated cataract surgery","volume":"31","author":"Verdina","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib151","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/jcm9041066","article-title":"The role of subthreshold micropulse yellow laser as an alternative option for the treatment of refractory postoperative cystoid macular edema","volume":"9","author":"Verdina","year":"2020","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.survophthal.2026.02.006_bib152","first-page":"6356","article-title":"Micropulse laser therapy for the treatment of longstanding refractory pseudophakic cystoid macular edema","volume":"55","author":"Aguirre","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib153","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0974-9233.65501","article-title":"Idiopathic juxtafoveolar retinal telangiectasis: a current review","volume":"17","author":"Nowilaty","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9394(00)00883-7","article-title":"Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture","volume":"131","author":"Shields","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","article-title":"Classification and management of Coats disease: the 2000 Proctor Lecture","volume":"131","author":"Shields","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib156","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3341\/kjo.2019.0071","article-title":"Subthreshold micropulse yellow laser (577 nm) for idiopathic macular telangiectasia type 1 resistant to intravitreal injection","volume":"34","author":"Kang","year":"2020","journal-title":"Korean J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib157","doi-asserted-by":"crossref","first-page":"NP29","DOI":"10.1177\/11206721211005691","article-title":"Subthreshold micropulse laser for adult onset coats\u2019 associated exudative maculopathy","volume":"32","author":"Kumar","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.006_bib158","first-page":"e278","article-title":"Long-term follow-up of an atypical case of idiopathic macular telangiectasia","volume":"49","author":"Mucciolo","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.006_bib159","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.iae.0000249561.02567.fd","article-title":"Retinal pigment epithelium produces matrix metalloproteinases after laser treatment","volume":"27","author":"Flaxel","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.006_bib160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000456028","article-title":"Yellow pattern 577-nm micropulse laser: treatment of macular edema from radiation retinopathy \u2013 a case report","volume":"8","author":"Wong","year":"2017","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.006_bib161","article-title":"Photodynamic therapy and subthreshold micropulse laser treatment \u2013 a novel combined approach for the treatment of serous retinal detachment in dome-shaped macula","volume":"31","author":"Pirani","year":"2020","journal-title":"Photodiagn Photodiagn Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib162","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/IAE.0000000000001524","article-title":"Subthreshold laser treatment for serous retinal detachment in dome-shaped macula associated with pathologic myopia","volume":"38","author":"Battaglia Parodi","year":"2018","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2026.02.006_bib163","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1167\/iovs.17-23098","article-title":"Nanosecond laser treatment for age-related macular degeneration does not induce focal vision loss or new vessel growth in the retina","volume":"59","author":"Vessey","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib164","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/IAE.0b013e3182670fea","article-title":"Retina rejuvenation therapy for diabetic macular edema: a pilot study","volume":"33","author":"Pelosini","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.02.006_bib165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40942-020-00214-3","article-title":"Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium","volume":"6","author":"Kaymak","year":"2020","journal-title":"Int J Retin Vitr"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.006_bib166","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s40123-024-00963-6","article-title":"Improvement in central serous chorioretinopathy following multiwavelength photobiomodulation treatment \u2013 case report","volume":"13","author":"Sachdev","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2026.02.006_bib167","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ophtha.2018.09.015","article-title":"Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial","volume":"126","author":"Guymer","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.006_bib168","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.oret.2016.12.001","article-title":"Subthreshold nanosecond laser intervention in intermediate age-related macular degeneration: study design and baseline characteristics of the laser in early stages of age-related macular degeneration study (report number 1)","volume":"1","author":"Lek","year":"2017","journal-title":"Ophthalmol Retin"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.006_bib169","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/biomedicines13040944","article-title":"Predictive factors for morphological and functional improvements in long-lasting central serous chorioretinopathy treated with photodynamic therapy","volume":"13","author":"Gaw\u0119cki","year":"2025","journal-title":"Biomedicines"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:44:50Z","timestamp":1779093890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":169,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0039625726000226"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.02.006","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}